Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Revenue

Ernexa Therapeutics had revenue of $1,000.00 in the twelve months ending September 30, 2025, down -99.83% year-over-year. In the year 2024, Ernexa Therapeutics had annual revenue of $582.00K with 755.88% growth.

• Revenue (ttm): $1,000.00
• Revenue Growth: -99.83%
• P/S Ratio: 9,104.71
• Revenue / Employee: $167
• Employees: 6
• Market Cap: 9.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	582.00K	514.00K	755.88%
Dec 31, 2023	68.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	19.81M	-3.53M	-15.12%
Dec 31, 2018	23.34M	2.06M	9.69%
Dec 31, 2017	21.27M	-1.04M	-4.65%
Dec 31, 2016	22.31M	-2.21M	-9.00%
Dec 31, 2015	24.52M	-1.53M	-5.86%
Dec 31, 2014	26.05M	2.30M	9.67%
Dec 31, 2013	23.75M	-315.00K	-1.31%
Dec 31, 2012	24.06M	194.00K	0.81%
Dec 31, 2011	23.87M	-1.44M	-5.69%
Dec 31, 2010	25.31M	-505.00K	-1.96%
Dec 31, 2009	25.81M	-1.68M	-6.12%
Dec 31, 2008	27.50M	-3.05M	-9.97%
Dec 31, 2007	30.54M	-2.44M	-7.41%
Dec 31, 2006	32.99M	2.24M	7.27%
Dec 31, 2005	30.75M	-	-